Randomized clinical trial to evaluate the utility of CYP2D6 genotyping to improve the efficacy and safety of tramadol in the treatment of acute postoperative pain

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500377-13-01

Acronym

Enrollment

300

Registered

2022-05-27

Start date

2022-10-05

Completion date

Unknown

Last updated

2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pharmakogenetics, Therapeutic techniques in treatment of acute postoperative pain

Brief summary

This is a simple study, which does not differ from standard clinical practice and therefore we do not expect early ending of the study.

Interventions

DRUGMetamizol Normon 575 mg cápsulas duras EFG.

DRUGParacetamol Normon 500 mg comprimidos EFG

DRUGDexketoprofeno Normon 25 mg comprimidos recubiertos con película EFG

DRUGTramadol Normon 50 mg cápsulas duras EFG

DRUGTramadol Normon 100 mg cápsulas duras

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
This is a simple study, which does not differ from standard clinical practice and therefore we do not expect early ending of the study.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026